Showing results (851-860 of 1,989) with videos related to
Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|January 9, 2013
Combining T-cell immunotherapy and anti-androgen therapy for prostate cancerC Sanchez, R Chan, P Bajgain, et al.Prostate Cancer and Prostatic Diseases|August 7, 2013
SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitroL Wang, J Zhang, X Yang, et al.Prostate Cancer and Prostatic Diseases|August 21, 2013
Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studiesA S Parker, D D Thiel, E Bergstralh, et al.Prostate Cancer and Prostatic Diseases|September 4, 2013
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomyM Rieken, L A Kluth, E Xylinas, et al.Prostate Cancer and Prostatic Diseases|October 9, 2013
Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH databaseE H Allott, M R Abern, L Gerber, et al.Prostate Cancer and Prostatic Diseases|July 24, 2013
Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expressionJ C Lloyd, E M Masko, C Wu, et al.Prostate Cancer and Prostatic Diseases|April 3, 2013
Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusionB Gumuskaya, B Gurel, H Fedor, et al.Prostate Cancer and Prostatic Diseases|September 24, 2014
A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancerT B Dorff, S Groshen, D D Tsao-Wei, et al.Prostate Cancer and Prostatic Diseases|October 16, 2013
Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)K E Bremner, N Mitsakakis, L Wilson, et al.Prostate Cancer and Prostatic Diseases|October 16, 2013
Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standardM Abd-Alazeez, A Kirkham, H U Ahmed, et al.Pageof 199